[HTML][HTML] Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
…, AS Peter, S Mueller-Schmucker, P Irrgang… - Nature …, 2021 - nature.com
Several effective SARS-CoV-2 vaccines are currently in use, but effective boosters are needed
to maintain or increase immunity due to waning responses and the emergence of novel …
to maintain or increase immunity due to waning responses and the emergence of novel …
[HTML][HTML] Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2
…, J Held, P Steininger, S Beileke, P Irrgang… - The Lancet Infectious …, 2021 - thelancet.com
The Oxford-AstraZeneca COVID-19 vaccine ChAdOx1 nCoV-19 is associated with a risk for
vaccineinduced immune thrombosis with thrombocytopenia syndrome in the range of one to …
vaccineinduced immune thrombosis with thrombocytopenia syndrome in the range of one to …
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination
P Irrgang, J Gerling, K Kocher, D Lapuente… - Science …, 2022 - science.org
RNA vaccines are efficient preventive measures to combat the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) pandemic. High levels of neutralizing SARS-CoV-2 …
syndrome coronavirus 2 (SARS-CoV-2) pandemic. High levels of neutralizing SARS-CoV-2 …
[HTML][HTML] Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®)
…, J Esse, K Tascilar, P Steininger, K Schober, P Irrgang… - Vaccines, 2021 - mdpi.com
mRNA vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
such as BNT162b2 (Comirnaty ® ), have proven to be highly immunogenic and efficient but …
such as BNT162b2 (Comirnaty ® ), have proven to be highly immunogenic and efficient but …
[HTML][HTML] Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2
D Lapuente, C Maier, P Irrgang, J Hübner… - European Journal of …, 2021 - Springer
SARS-CoV-2 has emerged as a previously unknown zoonotic coronavirus that spread
worldwide causing a serious pandemic. While reliable nucleic acid–based diagnostic assays …
worldwide causing a serious pandemic. While reliable nucleic acid–based diagnostic assays …
[HTML][HTML] Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2
…, BH Liao, N Körber, A Willmann, P Irrgang… - …, 2022 - thelancet.com
Background Vaccines are an important means to overcome the SARS-CoV-2 pandemic.
They induce specific antibody and T-cell responses but it remains open how well vaccine-…
They induce specific antibody and T-cell responses but it remains open how well vaccine-…
[HTML][HTML] Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity
C Maier, J Fuchs, P Irrgang, MH Wißing… - Frontiers in …, 2022 - frontiersin.org
Respiratory syncytial virus (RSV) infections are the leading cause of severe respiratory
illness in early infancy. Although the majority of children and adults mount immune responses …
illness in early infancy. Although the majority of children and adults mount immune responses …
XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors
…, N Schaft, J Dörrie, P Irrgang… - Proceedings of the …, 2023 - National Acad Sciences
Dendritic cells (DCs) are major regulators of innate and adaptive immune responses. DCs
can be classified into plasmacytoid DCs and conventional DCs (cDCs) type 1 and 2. Murine …
can be classified into plasmacytoid DCs and conventional DCs (cDCs) type 1 and 2. Murine …
[HTML][HTML] Adaptive immune responses are larger and functionally preserved in a hypervaccinated individual
…, F Drost, C Schülein, P Irrgang… - The Lancet Infectious …, 2024 - thelancet.com
Here, we report on a 62-year-old male hypervaccinated individual from Magdeburg, Germany
(HIM), who deliberately and for private reasons received 217 vaccinations against SARS-…
(HIM), who deliberately and for private reasons received 217 vaccinations against SARS-…
[HTML][HTML] Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections
T Huber, P Steininger, P Irrgang, K Korn… - European Journal of …, 2021 - Springer
SARS-CoV-2 antibody assays are used for epidemiological studies and for the assessment
of vaccine responses in highly vulnerable patients. So far, data on cross-reactivity of SARS-…
of vaccine responses in highly vulnerable patients. So far, data on cross-reactivity of SARS-…